710 related articles for article (PubMed ID: 17448867)
61. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure.
Pasciak AS; Abiola G; Liddell RP; Crookston N; Besharati S; Donahue D; Thompson RE; Frey E; Anders RA; Dreher MR; Weiss CR
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):816-827. PubMed ID: 31741021
[TBL] [Abstract][Full Text] [Related]
62. Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.
Fallahpoor M; Abbasi M; Parach AA; Kalantari F
J Appl Clin Med Phys; 2017 Mar; 18(2):176-180. PubMed ID: 28300366
[TBL] [Abstract][Full Text] [Related]
63. Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis.
Mascarenhas NB; Mulcahy MF; Lewandowski RJ; Salem R; Ryu RK
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):650-3. PubMed ID: 19688373
[TBL] [Abstract][Full Text] [Related]
64. General selection criteria of patients for radioembolization of liver tumors: an international working group report.
Coldwell D; Sangro B; Wasan H; Salem R; Kennedy A
Am J Clin Oncol; 2011 Jun; 34(3):337-41. PubMed ID: 20921882
[TBL] [Abstract][Full Text] [Related]
65. Ultrasound guided internal radiotherapy using yttrium-90 glass microspheres for liver malignancies.
Ho S; Lau WY; Leung WT
J Nucl Med; 1997 Jul; 38(7):1169-70. PubMed ID: 9225814
[No Abstract] [Full Text] [Related]
66. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Sarwar A; Kudla A; Weinstein JL; Ali A; Malik R; Bullock A; Khwaja KO; Curry M; Faintuch S; Ahmed M
Eur Radiol; 2021 Mar; 31(3):1316-1324. PubMed ID: 32901301
[TBL] [Abstract][Full Text] [Related]
67. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R
Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924
[TBL] [Abstract][Full Text] [Related]
68. Practical vascular anatomy in the preparation of radioembolization.
Paprottka PM; Jakobs TF; Reiser MF; Hoffmann RT
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):454-62. PubMed ID: 21567273
[TBL] [Abstract][Full Text] [Related]
69. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
Malhotra A; Liu DM; Talenfeld AD
Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710
[TBL] [Abstract][Full Text] [Related]
70. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method.
Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253
[TBL] [Abstract][Full Text] [Related]
71. A first report of radioembolization for hepatic metastases from ocular melanoma.
Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
[TBL] [Abstract][Full Text] [Related]
72. Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer.
Wang SC; Bester L; Burnes JP; Clouston JE; Hugh TJ; Little AF; Padbury RT; Price D
J Med Imaging Radiat Oncol; 2010 Jun; 54(3):178-87. PubMed ID: 20598004
[TBL] [Abstract][Full Text] [Related]
73. [Arterial radioembolization of malignant liver tumors by yttrium-90 microspheres].
Tarazov PG
Vopr Onkol; 2013; 59(4):428-34. PubMed ID: 24032215
[No Abstract] [Full Text] [Related]
74. Prospective, randomized study of coil embolization versus Surefire infusion system during yttrium-90 radioembolization with resin microspheres.
Fischman AM; Ward TJ; Patel RS; Arepally A; Kim E; Nowakowski FS; Lookstein RA
J Vasc Interv Radiol; 2014 Nov; 25(11):1709-16. PubMed ID: 25241302
[TBL] [Abstract][Full Text] [Related]
75. Personnel dose reduction in
Law M; Wong KK; Tso WK; Lee V; Luk MY; Tong CC; Chu F
Br J Radiol; 2017 Mar; 90(1071):20160591. PubMed ID: 27993095
[TBL] [Abstract][Full Text] [Related]
76. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.
Rafi S; Piduru SM; El-Rayes B; Kauh JS; Kooby DA; Sarmiento JM; Kim HS
Cardiovasc Intervent Radiol; 2013 Apr; 36(2):440-8. PubMed ID: 22956045
[TBL] [Abstract][Full Text] [Related]
77. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review.
Kao YH; Tan EH; Ng CE; Goh SW
Ann Nucl Med; 2011 Aug; 25(7):455-61. PubMed ID: 21643807
[TBL] [Abstract][Full Text] [Related]
78. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
Uthappa MC; Ravikumar R; Gupta A
Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
[TBL] [Abstract][Full Text] [Related]
79. [Radioembolization with (90)Y-labeled microspheres: post-therapeutic therapy validation with Bremsstrahlung-SPECT].
Grober OS; Nultsch M; Laatz K; Ulrich G; Seidensticker R; Pethe A; Dudeck O; Pech M; Knoop BO; Ricke J; Amthauer H; Geworski L
Z Med Phys; 2011 Dec; 21(4):274-80. PubMed ID: 21719264
[TBL] [Abstract][Full Text] [Related]
80. Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
Sag AA; Savin MA; Lal NR; Mehta RR
AJR Am J Roentgenol; 2014 May; 202(5):1130-5. PubMed ID: 24758670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
